Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniela Procházková"'
Autor:
Jaromír Šavelka, Pavel Loutocký, František Kasl, Adéla Kotková, Jakub Harašta, Daniela Procházková, Jakub Míšek, Jan Zibner, Helena Pullmannová, Michal Vosinek, Nikola Šimková, Petr Semenišín, Tamara Šejnová, Lucie Zavadilová
Publikováno v:
Text, Speech, and Dialogue ISBN: 9783030007935
TSD
TSD
We describe an annotated corpus of 350 decisions of Czech top-tier courts which was gathered for a project assessing the relevance of court decisions in Czech law. We describe two layers of processing of the corpus; every decision was annotated by tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68b71550d0c4afb913c22d06d7056685
https://doi.org/10.1007/978-3-030-00794-2_26
https://doi.org/10.1007/978-3-030-00794-2_26
Autor:
Kateřina, Zdráhalová, Jaroslav, Štěrba, Jiří, Domanský, Bohumír, Blažek, Hana, Ptoszková, Vladimír, Mihál, Zbyněk, Novák, Jiří, Hak, Daniela, Procházková, Zdena, Černá, Pavel, Timr, Yahia, Jabali, Petr, Sedláček, Petr, Smíšek, Zuzana, Zemanová, Marie, Jarošová, Alena, Houdková, Ester, Mejstříková, Ondřej, Hrušák, Jan, Zuna, Iveta, Janotová, Jan, Trka, Jan, Starý
Publikováno v:
Casopis lekaru ceskych. 154(2)
Acute lymphoblastic leukemia (ALL) is the most frequent childhood malignancy. Treatment has been unified in the middle of 1980 in the Czech Republic. In 2002-2007 children and adolescents with acute lymphoblastic leukemia were treated in an internati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db644176826787d2adf73ae442860f27
https://pubmed.ncbi.nlm.nih.gov/25994910
https://pubmed.ncbi.nlm.nih.gov/25994910
Autor:
Jana Volejnikova, Ester Mejstrikova, Tatana Valova, Leona Reznickova, Ladislava Hodonska, Vladimir Mihal, Jaroslav Sterba, Yahia Jabali, Daniela Prochazkova, Bohumir Blazek, Jiri Hak, Zdenka Cerna, Ondrej Hrusak, Jan Stary, Jan Trka, Eva Fronkova
Publikováno v:
Haematologica, Vol 96, Iss 12 (2011)
Background Most minimal residual disease-directed treatment interventions in current treatment protocols for acute lymphoblastic leukemia are based on bone marrow testing, which is a consequence of previous studies showing the superiority of bone mar
Externí odkaz:
https://doaj.org/article/56f8f534185b4b1abc8f07c8bc916afb
Autor:
Ester Mejstrikova, Jana Volejnikova, Eva Fronkova, Katerina Zdrahalova, Tomas Kalina, Jaroslav Sterba, Yahia Jabali, Vladimir Mihal, Bohumir Blazek, Zdena Cerna, Daniela Prochazkova, Jiri Hak, Zuzana Zemanova, Marie Jarosova, Alexandra Oltova, Petr Sedlacek, Jiri Schwarz, Jan Zuna, Jan Trka, Jan Stary, Ondrej Hrusak
Publikováno v:
Haematologica, Vol 95, Iss 6 (2010)
Background Mixed phenotype acute leukemia (MPAL) represents a diagnostic and therapeutic dilemma. The European Group for the Immunological Classification of Leukemias (EGIL) scoring system unambiguously defines MPAL expressing aberrant lineage marker
Externí odkaz:
https://doaj.org/article/00e3c2b1f9cb4fb2adcf9b49b33ebc86